Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...
DUBLIN, Ireland--(BUSINESS WIRE)-- Covidien (NYSE: COV) today announced CE Mark approval for its Nellcor™ Bedside SpO 2 Patient Monitoring System, PM100N. The system currently is available in the ...
On June 21, Covidien plc ( COV), global innovator and manufacturer of healthcare products, announced the launch of Nellcor SpO 2 single parameter module in North America, European Economic Area (EEA) ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
BOULDER, Colo.--(BUSINESS WIRE)--Every year, nearly 7,200 infants are born in the United States with a Critical Congenital Heart Disease (CCHD). 1 It is a condition that is often easily detectable and ...
Nellcor pulse oximeters only FDA 510(k)-cleared oximeters compliant with ISO 80601-2-61 BOULDER, Colo.--(BUSINESS WIRE)-- Covidien, a leading global provider of healthcare products and recognized ...
BOULDER, Colo.--(BUSINESS WIRE)-- Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today ...
OBJECTIVES: Pulse oximetry is widely used in the NICU, but clinicians often distrust the displayed values during patient motion, i.e., questionable oxygen saturation (SpO 2) and pulse rate (PR) values ...
Medtronic plc MDT recently announced favourable outcome of an independent prospective observational study, which was published online in the Journal of Perinatology. This study compared the efficacy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback